Matthias Staufenbiel

33.6k total citations · 7 hit papers
214 papers, 25.1k citations indexed

About

Matthias Staufenbiel is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Matthias Staufenbiel has authored 214 papers receiving a total of 25.1k indexed citations (citations by other indexed papers that have themselves been cited), including 176 papers in Physiology, 102 papers in Molecular Biology and 50 papers in Cellular and Molecular Neuroscience. Recurrent topics in Matthias Staufenbiel's work include Alzheimer's disease research and treatments (169 papers), Prion Diseases and Protein Misfolding (39 papers) and Cholinesterase and Neurodegenerative Diseases (38 papers). Matthias Staufenbiel is often cited by papers focused on Alzheimer's disease research and treatments (169 papers), Prion Diseases and Protein Misfolding (39 papers) and Cholinesterase and Neurodegenerative Diseases (38 papers). Matthias Staufenbiel collaborates with scholars based in Switzerland, Germany and United States. Matthias Staufenbiel's co-authors include Mathias Jucker, Dorothée Abramowski, Karl‐Heinz Wiederhold, Christine Stürchler-Pierrat, Bernd Sommer, A. Probst, Markus Tolnay, Paolo Paganetti, Tristan Bolmont and Stephan A. Kaeser and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Matthias Staufenbiel

212 papers receiving 24.6k citations

Hit Papers

Dendritic Function of Tau Mediates Amyloid-β To... 1997 2026 2006 2016 2010 2009 1997 2008 2006 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
    2010 1.4k citations Anne Eckert, Matthias Staufenbiel et al. profile →
  2. Transmission and spreading of tauopathy in transgenic mouse brain
    2009 1.3k citations Dorothée Abramowski, Matthias Staufenbiel et al. profile →
  3. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
    1997 1.2k citations Christine Stürchler-Pierrat, Dorothée Abramowski et al. Proceedings of the National Academy of Sciences profile →
  4. Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer's Disease
    2008 841 citations Marc Aurel Busche, Gerhard Eichhoff et al. Science profile →
  5. Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host
    2006 744 citations Stephan A. Kaeser, Dorothée Abramowski et al. Science profile →
  6. Brain homogenates from human tauopathies induce tau inclusions in mouse brain
    2013 563 citations Julia Reichwald, Matthias Staufenbiel et al. Proceedings of the National Academy of Sciences profile →
  7. Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer’s disease
    2012 525 citations Marc Aurel Busche, Xiaowei Chen et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthias Staufenbiel Switzerland 85 16.8k 9.5k 6.5k 6.2k 3.5k 214 25.1k
Marcia N. Gordon United States 54 14.5k 0.9× 6.9k 0.7× 4.8k 0.7× 6.2k 1.0× 3.2k 0.9× 135 20.7k
Karen Duff United States 89 18.0k 1.1× 10.9k 1.2× 9.6k 1.5× 5.2k 0.8× 4.1k 1.2× 236 29.5k
Steven G. Younkin United States 56 17.1k 1.0× 8.9k 0.9× 4.8k 0.7× 4.3k 0.7× 4.1k 1.2× 103 21.6k
Mathias Jucker Germany 73 13.8k 0.8× 9.8k 1.0× 4.5k 0.7× 7.0k 1.1× 2.0k 0.6× 179 22.5k
Todd E. Golde United States 94 18.8k 1.1× 14.2k 1.5× 5.7k 0.9× 5.4k 0.9× 5.3k 1.5× 314 32.1k
Frank M. LaFerla United States 97 23.2k 1.4× 13.1k 1.4× 10.1k 1.6× 8.0k 1.3× 6.3k 1.8× 248 36.7k
Brian J. Bacskai United States 75 10.4k 0.6× 6.3k 0.7× 5.5k 0.8× 4.2k 0.7× 2.4k 0.7× 194 19.6k
Dave Morgan United States 47 12.0k 0.7× 5.8k 0.6× 4.0k 0.6× 5.5k 0.9× 2.6k 0.7× 106 17.8k
Thomas Wısnıewskı United States 76 11.7k 0.7× 8.8k 0.9× 3.4k 0.5× 4.0k 0.6× 2.3k 0.7× 389 20.5k
Peter Davies United States 80 14.0k 0.8× 8.4k 0.9× 5.9k 0.9× 4.5k 0.7× 2.9k 0.8× 232 22.9k

Countries citing papers authored by Matthias Staufenbiel

Since Specialization
Citations

This map shows the geographic impact of Matthias Staufenbiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Staufenbiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Staufenbiel more than expected).

Fields of papers citing papers by Matthias Staufenbiel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Staufenbiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Staufenbiel. The network helps show where Matthias Staufenbiel may publish in the future.

Co-authorship network of co-authors of Matthias Staufenbiel

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Staufenbiel. A scholar is included among the top collaborators of Matthias Staufenbiel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Staufenbiel. Matthias Staufenbiel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koper, Marta J., Alicja Ronisz, Simona Ospitalieri, et al.. (2024). Inhibition of an Alzheimer’s disease–associated form of necroptosis rescues neuronal death in mouse models. Science Translational Medicine. 16(771). eadf5128–eadf5128. 7 indexed citations
2.
Eninger, Timo, Stephan A. Müller, Mehtap Bacioglu, et al.. (2022). Signatures of glial activity can be detected in the CSF proteome. Proceedings of the National Academy of Sciences. 119(24). e2119804119–e2119804119. 15 indexed citations
3.
Veenstra, Siem J., Heinrich Rueeger, Philipp Holzer, et al.. (2018). Discovery of amino-1,4-oxazines as potent BACE-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(12). 2195–2200. 10 indexed citations
4.
Adelsberger, Helmuth, Ulf Neumann, Derya R. Shimshek, et al.. (2017). BACE inhibition-dependent repair of Alzheimer’s pathophysiology. Proceedings of the National Academy of Sciences. 114(32). 8631–8636. 98 indexed citations
5.
Reuter, Björn, Saskia Grudzenski, Lothar R. Schad, et al.. (2016). Statin Therapy and the Development of Cerebral Amyloid Angiopathy—A Rodent in Vivo Approach. International Journal of Molecular Sciences. 17(1). 126–126. 6 indexed citations
6.
Langer, Franziska, Jasmin Mahler, Angelos Skodras, et al.. (2016). Conversion of Synthetic Aβ toIn VivoActive Seeds and Amyloid Plaque Formation in a Hippocampal Slice Culture Model. Journal of Neuroscience. 36(18). 5084–5093. 33 indexed citations
7.
8.
Busche, Marc Aurel, Xiaowei Chen, Julia Reichwald, et al.. (2012). Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer’s disease. Proceedings of the National Academy of Sciences. 109(22). 8740–8745. 525 indexed citations breakdown →
9.
Shepherd, Claire E., Glenda M. Halliday, Masaaki Kobayashi, et al.. (2012). Role of hippocalcin in mediating Aβ toxicity. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1822(8). 1247–1257. 9 indexed citations
10.
Langer, Franziska, Yvonne S. Eisele, Sarah K. Fritschi, et al.. (2011). Soluble Aβ Seeds Are Potent Inducers of Cerebral β-Amyloid Deposition. Journal of Neuroscience. 31(41). 14488–14495. 186 indexed citations
11.
Reichwald, Julia, et al.. (2011). The Swedish APP mutation alters the effect of genetically reduced BACE1 expression on the APP processing. Journal of Neurochemistry. 119(1). 231–239. 23 indexed citations
12.
Reichwald, Julia, Simone Danner, Karl‐Heinz Wiederhold, & Matthias Staufenbiel. (2009). Expression of complement system components during aging and amyloid deposition in APP transgenic mice. Journal of Neuroinflammation. 6(1). 35–35. 91 indexed citations
13.
Busche, Marc Aurel, Gerhard Eichhoff, Helmuth Adelsberger, et al.. (2008). Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer's Disease. Science. 321(5896). 1686–1689. 841 indexed citations breakdown →
14.
Staufenbiel, Matthias, Karl‐Heinz Wiederhold, Alain C. Tissot, et al.. (2006). O1–06–01: Immunization with Aβ1–6 coupled to the virus–like particle Qβ (CAD106) efficiently removes β–amyloid without inducing Aβ–reactive T–cells. Alzheimer s & Dementia. 2(3S_Part_1). 2 indexed citations
15.
Dam, Debby Van, Bart Marescau, Sebastiaan Engelborghs, et al.. (2005). Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models. Neurochemistry International. 46(5). 409–422. 34 indexed citations
16.
Koldamova, Radosveta, Iliya Lefterov, Matthias Staufenbiel, et al.. (2004). The Liver X Receptor Ligand T0901317 Decreases Amyloid β Production in Vitro and in a Mouse Model of Alzheimer's Disease. Journal of Biological Chemistry. 280(6). 4079–4088. 225 indexed citations
17.
Cataldo, Anne M., Suzana Petanceska, Corrinne M. Peterhoff, et al.. (2003). AppGene Dosage Modulates Endosomal Abnormalities of Alzheimer's Disease in a Segmental Trisomy 16 Mouse Model of Down Syndrome. Journal of Neuroscience. 23(17). 6788–6792. 187 indexed citations
18.
Kuo, Yu‐Min, Tyler A. Kokjohn, Thomas G. Beach, et al.. (2001). Comparative Analysis of Amyloid-β Chemical Structure and Amyloid Plaque Morphology of Transgenic Mouse and Alzheimer's Disease Brains. Journal of Biological Chemistry. 276(16). 12991–12998. 216 indexed citations
19.
Paganetti, Paolo, et al.. (1996). Amyloid precursor protein truncated at any of the ?-secretase sites is not cleaved to ?-amyloid. Journal of Neuroscience Research. 46(3). 283–293. 32 indexed citations
20.
Staufenbiel, Matthias. (1987). Ankyrin-Bound Fatty Acid turns over Rapidly at the Erythrocyte Plasma Membrane. Molecular and Cellular Biology. 7(8). 2981–2984. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcia N. Gordon Breakdown of academic impact, for papers by Karen Duff Breakdown of academic impact, for papers by Steven G. Younkin Breakdown of academic impact, for papers by Mathias Jucker Breakdown of academic impact, for papers by Todd E. Golde Breakdown of academic impact, for papers by Frank M. LaFerla Breakdown of academic impact, for papers by Brian J. Bacskai Breakdown of academic impact, for papers by Dave Morgan Breakdown of academic impact, for papers by Thomas Wısnıewskı Breakdown of academic impact, for papers by Peter Davies
Rankless by CCL
2026